SR
Siva Ramakrishna Undamatla
About Siva Ramakrishna Undamatla
Data last updated:
Siva Ramakrishna Undamatla is a Director at Ramanand Pharmaceuticals Private Limited (since 2019), Director at Consum Pharma Solutions Private Limited (since 2021) and Partner at Ortemis Pharma Solutions Llp (since 2023), and holds 1 more current directorship. The companies operate in Pharma and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹52.3 Lakh; the largest is Ramanand Pharmaceuticals Private Limited at ₹34 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Dec 2019 | 2019 | ₹34 Lakh (FY 2025) | Active | |
| Director | 03 Jun 2021 | 2021 | ₹18.3 Lakh (FY 2025) | Active | |
| Partner | 15 May 2023 | 2023 | Active | ||
| Designated Partner | 19 Dec 2022 | 2022 | Active |
Board colleagues of Siva Ramakrishna Undamatla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naga Bandaru Jaya Sri | 09193157 | Ramanand Pharmaceuticals Private Limited , Consum Pharma Solutions Private Limited and 1 more | Director |
| Chandra Kumar Verma | 09813215 | Ortemis Pharma Solutions Llp | Designated Partner |
| Mayur Devjibhai Khunt | 10163586 | Ortemis Pharma Solutions Llp | Designated Partner |
| Vinod Govindakutty Tazhekattu | 10163585 | Ortemis Pharma Solutions Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Siva Ramakrishna Undamatla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siva Ramakrishna Undamatla
Siva Ramakrishna Undamatla currently holds 4 directorships: Ramanand Pharmaceuticals Private Limited (Director, since 09 Dec 2019, revenue ₹34 Lakh (FY 2025)); Consum Pharma Solutions Private Limited (Director, since 03 Jun 2021, revenue ₹18.3 Lakh (FY 2025)); Ortemis Pharma Solutions Llp (Partner, since 15 May 2023); Squadhex Pharma Services Llp (Designated Partner, since 19 Dec 2022).
Siva Ramakrishna Undamatla was first appointed on 09 Dec 2019 as Director at Ramanand Pharmaceuticals Private Limited. The most recent appointment on record is 15 May 2023 at Ortemis Pharma Solutions Llp.
The 2 current companies of Siva Ramakrishna Undamatla that report revenue have a combined latest revenue of ₹52.3 Lakh: Ramanand Pharmaceuticals Private Limited ₹34 Lakh (FY 2025); Consum Pharma Solutions Private Limited ₹18.3 Lakh (FY 2025).
The current boards of Siva Ramakrishna Undamatla's companies include Naga Bandaru Jaya Sri (Ramanand Pharmaceuticals Private Limited), Chandra Kumar Verma (Ortemis Pharma Solutions Llp), Mayur Devjibhai Khunt (Ortemis Pharma Solutions Llp), Vinod Govindakutty Tazhekattu (Ortemis Pharma Solutions Llp).